We are live on ! Find out more

Addus HomeCare

ADUS

Market cap $2.28B

122.18 USD

+0.94

0.78%

At close Updated Oct 28, 4:00 PM EDT

Pre-market

After hours

122.41

+0.23

0.19%

1 day

0.78%

5 days

2.86%

1 month

9.18%

3 months

2.48%

6 months

23.61%

Year to date

14.64%

1 year

1.37%

5 years

39.65%

10 years

389.5%

About: Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.

Employees: 50,659

Healthcare Medical Care Facilities

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 36.4%

Neutral 63.6%

Negative 0%

Addus HomeCare Announces Third Quarter 2026 Earnings Release and Conference Call

FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the third quarter ended September 30, 2026, on Tuesday, November 3, 2026, after the market close. Addus HomeCare will host a conference call on Wednesday, November 4, 2026, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, and Brian Poff, Executive Vice President and CFO. To access the li.

Addus HomeCare Announces Third Quarter 2026 Earnings Release and Conference Call

Addus HomeCare Announces a Definitive Agreement to Acquire Personal Care Division of AccentCare

FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced a definitive agreement to acquire the personal care division of AccentCare for an anticipated purchase price, after customary purchase price adjustments, of approximately $275.0 million. The transaction relates only to AccentCare's personal care operations outside of New York and does not relate to its hospice and home health operations. The acquired operations serve an a.

Addus HomeCare Announces a Definitive Agreement to Acquire Personal Care Division of AccentCare

Addus HomeCare to Participate in the 2026 Jefferies Healthcare Services and Technology Conference

FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Brian Poff, Executive Vice President and Chief Financial Officer, and Brad Bickham, Chief Operating Officer on an Interim Basis, will participate in the 2026 Jefferies Healthcare Services and Technology Conference, September 14 - 15, 2026, in Nashville, Tennessee. In connection with the conference, there will be a live broadcast and replay of the Company's presentati.

Addus HomeCare to Participate in the 2026 Jefferies Healthcare Services and Technology Conference

Zacks Investment Research

Addus HomeCare (ADUS) Just Flashed Golden Cross Signal: Do You Buy?

Addus HomeCare Corporation (ADUS) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ADUS's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.

Addus HomeCare (ADUS) Just Flashed Golden Cross Signal: Do You Buy?

Addus HomeCare Announces Departure of Heather Dixon and Return of Brad Bickham as Chief Operating Officer on an Interim Basis

FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS) (the “Company”), a provider of home care services, announced today that Heather Dixon, President and Chief Operating Officer, is no longer with the Company. Brad Bickham, former President and Chief Operating Officer at Addus, has agreed to return as Chief Operating Officer on an interim basis, effective immediately, for a period of one year. “On behalf of the Board and the entire company, I want to thank Heather for her d.

Addus HomeCare Announces Departure of Heather Dixon and Return of Brad Bickham as Chief Operating Officer on an Interim Basis

Zacks Investment Research

ADUS vs. ELAN: Which Stock Is the Better Value Option?

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and Elanco Animal Health Incorporated (ELAN). But which of these two stocks offers value investors a better bang for their buck right now?

ADUS vs. ELAN: Which Stock Is the Better Value Option?

Addus HomeCare Corporation (ADUS) Q2 2026 Earnings Call Transcript

Addus HomeCare Corporation (ADUS) Q2 2026 Earnings Call Transcript

Addus HomeCare Corporation (ADUS) Q2 2026 Earnings Call Transcript

Addus HomeCare Q2 Earnings Call Highlights

Addus HomeCare NASDAQ: ADUS reported second-quarter 2026 revenue growth of 8% and adjusted earnings-per-share growth of 16.1%, supported by expansion in personal care and hospice services, improved cash generation and ongoing acquisition activity.

Addus HomeCare Q2 Earnings Call Highlights

Zacks Investment Research

Addus HomeCare (ADUS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

The headline numbers for Addus HomeCare (ADUS) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Addus HomeCare (ADUS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks Investment Research

Addus HomeCare (ADUS) Surpasses Q2 Earnings and Revenue Estimates

Addus HomeCare (ADUS) came out with quarterly earnings of $1.73 per share, beating the Zacks Consensus Estimate of $1.69 per share. This compares to earnings of $1.49 per share a year ago.

Addus HomeCare (ADUS) Surpasses Q2 Earnings and Revenue Estimates

See News Rankings

Price charts implemented using Lightweight Charts™